https://scholars.lib.ntu.edu.tw/handle/123456789/596659
標題: | Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors | 作者: | Hsu, Chia-Yun WEN-JONE CHEN Chen, Ho-Ming Tsai, Hsin-Yi FEI-YUAN HSIAO |
關鍵字: | atherosclerosis; cardiovascular disease; reimbursement criteria; risk factors; statin | 公開日期: | 四月-2021 | 出版社: | WILEY | 卷: | 46 | 期: | 2 | 起(迄)頁: | 415 | 來源出版物: | Journal of clinical pharmacy and therapeutics | 摘要: | Starting 1 August 2013, the eligible cholesterol level for statin reimbursement in patients with atherosclerotic cardiovascular disease (ASCVD) or cardiovascular disease (CVD)-related risk factors changed from LDL-C ≥ 130 mg/dl (or TC ≥ 200 mg/dl) to LDL-C ≥ 100 mg/dl (or TC ≥ 160 mg/dl) in Taiwan, which may modify clinician prescribing behaviours. We aimed to evaluate the impact of changing reimbursement criteria on statin treatment patterns. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/596659 | ISSN: | 0269-4727 | DOI: | 10.1111/jcpt.13299 | SDG/關鍵字: | atorvastatin; cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; pitavastatin; rosuvastatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; adult; Article; cardiovascular risk; cerebrovascular di |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。